PNT News
Archived Headlines
- RA Capital's SPAC Therapeutics Acquisition prices upsized $118 million IPO at $10 07/08/20
- Warrantless but not unwarranted: Therapeutics Acquisition prices first ever SPAC IPO of common shares 07/08/20
- US IPO Week Ahead: Third quarter kicks off with China’s largest gay dating app 07/02/20
- US IPO Weekly Recap: Royalty Pharma takes the crown in 5 IPO week 06/19/20
- RA Capital's SPAC Therapeutics Acquisition files for a $100 million IPO 06/15/20
28 SPAC mergers that have outperformed in 2023
After a dismal 2022, a number of SPAC mergers have outperformed this year alongside a strong rebound in IPO returns and the broader stock market. While most de-SPACs continue to trade below the $10 transaction price, investors may be finding hidden gems among...read more
2020 is officially the busiest year ever for SPACs as deal count reaches a new high
With three SPAC offerings completed yesterday, the number of year-to-date SPAC IPOs has now exceeded the previous year's record breaking count. So far in 2020, 60 SPACs have raised $22.5 billion, all-time highs for both count and proceeds with nearly five...read more
Bill Ackman's Pershing Square Tontine joins a long list of 2020 SPAC milestones
Pershing Square Tontine Holdings (PSTHU) raised $4 billion and traded up 6.5% yesterday, becoming the largest Special Purpose Acquisition Company (SPAC) ever to go public. It is the latest milestone in a record-breaking year for SPACs. To screen for...read more
US IPO Weekly Recap: Preclinical biotech Nkarta pops 166% in a 5 IPO week
Three biotechs, two Chinese issuers, and one SPAC went public this past week, led by preclinical oncology biotech Nkarta (NKTX), which popped 166% in the best first-day return for a $10+ million IPO since 2015. Some major news hit the IPO pipeline this...read more